FundingWatcher
Home / Startups / Top biotech startups / Biotech startups in the United Kingdom

Biotech startups in the United Kingdom

Updated 16 Nov 2026

Reset
Biotech startups in the United Kingdom
One-time CSV
  • 638 funded companies, 396 with a website
  • Last round, amount, date, total raised and investors
  • CRM-ready CSV, 18 columns
  • Download right after payment
With founder contacts
Compiled to order
  • The full startup CSV, plus founders and executives
  • Up to 2 founders or CEOs per company, compiled to order
  • Name, job title and LinkedIn URL where found
  • Verified direct email per person
  • Startup CSV at once, contacts CSV by mail within 24 hours
Download right after paymentFree 10-row sampleSecure checkout by Stripe

Not sure about the data?

Download a free 10-row sample first. No account, no payment.

startups-biotech~united-kingdom.csv638 rows × 18 columns
CompanyCityLast roundAmountDate
bit.bioCambridgeSeries D$25.0M2026-11-04
T-TherapeuticsCambridgeSeries B$133.0M2026-11-05
Basecamp ResearchLondonSeries C$140.0M2026-09-23
BrainomixOxfordSeries C$6.5M2026-02-24
MicrobioticaCambridgeSeries C$47.9M2026-10-16
BiolibertyEdinburghSeries A$3.3M2026-11-02
SparxellCambridgeSeed$5.0M2026-02-03
Alchemab TherapeuticsLondonSeries A$33.6M2026-07-09

8 rows of the CSV in 5 of its 18 columns.

638
Startups
$10.6B
Total raised
90
Funded in the last 12 months
$2.3B
Raised in the last 12 months

Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.

Newest rounds

30 of 638
30 rows
Company What they do Sector City Last round Amount Date Total raised Investors Employees Founded
T-Therapeutics T-Therapeutics develops T cell receptor therapies, spun off from the University of Cambridge. Biotech Cambridge Series B $133.0M 2026-11-05 $224.6M F-Prime, Sofinnova Partners, Digitalis Ventures +2 51 to 100 2022
bit.bio Bit.bio provides engineered human cell products and platform services for biomedical research and drug discovery. Biotech Cambridge Series D $25.0M 2026-11-04 $250.0M Metaplanet, Foresite Capital 101 to 250 2016
Bioliberty Bioliberty develops rehabilitation solutions for degenerative and traumatic conditions as a medtech start-up. Biotech Edinburgh Series A $3.3M 2026-11-02 $17.4M Innovate UK, Scottish Enterprise, Old College Capital +2 11 to 50 2020
Microbiotica Microbiotica develops live bacterial microbiome therapeutics and associated biomarkers. Biotech Cambridge Series C $47.9M 2026-10-16 $130.7M Seventure Partners, IP Group, Cambridge Innovation Capital +1 11 to 50 2016
Sava Technology Sava Technology creates under-skin sensors that continuously monitor glucose, lactate, and ketones. Biotech London Series B $36.0M 2026-10-09 $62.8M SOSV, Balderton Capital, Social Starts +1 101 to 250 2016
Basecamp Research Basecamp Research is a biotechnology company that uses AI and biological data to develop therapeutics. Artificial intelligence London Series C $140.0M 2026-09-23 $219.9M True Ventures, redalpine, Hummingbird Ventures +1 51 to 100 2019
Mironid Mironid discovers drugs to treat degenerative kidney diseases, chronic inflammatory diseases, and cancer. Biotech Glasgow Series B $45.9M 2026-08-05 $90.6M Scottish Enterprise, Sofinnova Partners, European Investment Fund +1 11 to 50 2014
Alchemab Therapeutics Alchemab Therapeutics develops protective antibodies to prevent hard-to-treat diseases. Biotech London Series A $33.6M 2026-07-09 $151.1M DCVC, RA Capital Management, DHVC +2 51 to 100 2019
Automata Automata provides laboratory automation software and hardware to increase efficiency in scientific workflows. Artificial intelligence London Series C $45.0M 2026-06-25 $144.8M Octopus Ventures, Firstminute Capital, Hummingbird Ventures +1 101 to 250 2015
Apoha Apoha is a start-up that has not yet publicly launched. Biotech London Series A $36.0M 2026-06-03 $36.0M Plug and Play, Innovate UK, Intel Ignite +2 1 to 10 2021
Imperagen Imperagen is a biotechnology company that researches enzyme engineering, artificial intelligence, and synthetic biology. Artificial intelligence Manchester Seed $6.7M 2026-05-20 $11.0M IQ Capital, Northern Gritstone 11 to 50 2021
CellCentric CellCentric develops small molecule therapies for treating cancer and multiple myeloma. Biotech Cambridge Series D $220.0M 2026-05-06 $475.7M Innovate UK, 5Y Capital, RA Capital Management +2 11 to 50 2003
Fermtech Fermtech provides equipment that helps precision fermentation companies scale production processes. Biotech Oxford Seed $3.3M 2026-04-07 $3.9M Carbon13 1 to 10 2022
Corryn Biotechnologies Corryn Biotechnologies develops wound dressing devices for chronic and complex wounds. Biotech Morriston Seed $662K 2026-04-01 $1.6M SFC Capital, Innovate UK 1 to 10 2021
Lucida Medical Lucida Medical develops software for cancer diagnosis using MRI and radiology imaging, particularly for prostate cancer. Biotech Cambridge Series A $11.5M 2026-03-30 $22.5M Innovate UK, XTX Ventures, WDH Investments 11 to 50 2019
Brainomix Brainomix creates AI-powered imaging biomarkers that support precision medicine treatment decisions. Artificial intelligence Oxford Series C $6.5M 2026-02-24 $60.2M Innovate UK, Parkwalk Advisors, Boehringer Ingelheim Venture Fund +1 51 to 100 2010
sable bio Sable Bio uses artificial intelligence to analyze large biomedical datasets and test drug candidates for toxicity. Artificial intelligence London Seed $3.8M 2026-02-11 $5.6M Seedcamp, Episode 1 1 to 10 2023
Early Health Early Health makes consumer bathroom hardware that detects early signs of illness. Biotech London Seed $4.7M 2026-02-10 $4.7M LocalGlobe, SoftBank Vision Fund, Atomico +1 1 to 10 2022
KluraLabs KluraLabs manufactures products that use nanotechnology to inactivate viruses and bacteria. Biotech Haverhill Series A $11.0M 2026-02-03 $11.0M Starship Ventures 11 to 50 2020
Sparxell Sparxell creates new colors and effects. Biotech Cambridge Seed $5.0M 2026-02-03 $10.2M Katapult, Joyance Partners, Earth Venture Capital +1 11 to 50 2022
Infinitopes Infinitopes develops vaccines for the treatment of cancer. Biotech Oxford Seed $15.4M 2026-01-21 $31.4M Octopus Ventures, Kindred Capital, Martlet Capital +1 11 to 50 2021
Nuclera Nuclera provides a protein prototyping system that makes proteins readily available to drug discovery researchers. Biotech Cambridge Series C $12.0M 2026-01-13 $157.8M Innovate UK, Verve Ventures, Amadeus Capital Partners +2 101 to 250 2013
EpilepsyGTx EpilepsyGTx develops gene therapies to improve management of focal refractory epilepsy in late-stage clinical development. Biotech Canterbury Series A $33.0M 2025-12-10 $43.0M UCL Technology Fund, HTH 1 to 10 2021
Emm Emm develops bio-wearable devices intended to improve healthcare. Biotech London Seed $8.9M 2025-11-19 $9.9M Alumni Ventures, Innovate UK, Sie Ventures 11 to 50 2020
InvenireX InvenireX offers molecular diagnostics services as a biotechnology company. Biotech Newcastle Upon Tyne Seed $2.6M 2025-11-18 $3.3M XTX Ventures, DSW Ventures 1 to 10 2021
OXCCU OXCCU converts carbon dioxide and hydrogen into synthetic fuels, chemicals, and biodegradable plastics. Biotech Oxford Series B $27.9M 2025-09-29 $54.1M IP Group, Aramco Ventures, Clean Energy Ventures +1 1 to 10 2021
Cyted Cyted uses AI and digital pathology to improve the detection and diagnosis of diseases, including cancer. Artificial intelligence Cambridge Series B $44.0M 2025-08-30 $83.4M Innovate UK, MedTech Innovator, Morningside +1 51 to 100 2018
Verdiva Bio Verdiva Bio develops treatments for patients with obesity and cardiometabolic diseases. Biotech London Series A $411.0M 2025-01-09 $411.0M General Atlantic, RA Capital Management, OrbiMed +1 11 to 50 2024
OxCan OxCan develops machine learning and liquid biopsy tools for early lung cancer detection. Biotech Oxford Series A $11.0M 2025-01-09 $16.4M Civilization Ventures, Eka Ventures, Oxford Technology Management +1 11 to 50 2020
Amped PCR Amped PCR manufactures reagents and develops PurifAI. Artificial intelligence Cardiff Seed $679K 2024-12-16 SFC Capital 1 to 10 2022

Table 1. Biotech startups in the United Kingdom: the 30 newest rounds whose row carries a description, a city, a named fund and an amount. Source: FundingWatcher. Data as of 16 November 2026. Base: 638.

Largest rounds

Last 12 months
10 rows
# Company What they do Sector City Last round Amount Date Total raised Investors Employees Founded
1 CellCentric CellCentric develops small molecule therapies for treating cancer and multiple myeloma. Biotech Cambridge Series D $220.0M 2026-05-06 $475.7M Innovate UK, 5Y Capital, RA Capital Management +2 11 to 50 2003
2 Basecamp Research Basecamp Research is a biotechnology company that uses AI and biological data to develop therapeutics. Artificial intelligence London Series C $140.0M 2026-09-23 $219.9M True Ventures, redalpine, Hummingbird Ventures +1 51 to 100 2019
3 T-Therapeutics T-Therapeutics develops T cell receptor therapies, spun off from the University of Cambridge. Biotech Cambridge Series B $133.0M 2026-11-05 $224.6M F-Prime, Sofinnova Partners, Digitalis Ventures +2 51 to 100 2022
4 Microbiotica Microbiotica develops live bacterial microbiome therapeutics and associated biomarkers. Biotech Cambridge Series C $47.9M 2026-10-16 $130.7M Seventure Partners, IP Group, Cambridge Innovation Capital +1 11 to 50 2016
5 Mironid Mironid discovers drugs to treat degenerative kidney diseases, chronic inflammatory diseases, and cancer. Biotech Glasgow Series B $45.9M 2026-08-05 $90.6M Scottish Enterprise, Sofinnova Partners, European Investment Fund +1 11 to 50 2014
6 Automata Automata provides laboratory automation software and hardware to increase efficiency in scientific workflows. Artificial intelligence London Series C $45.0M 2026-06-25 $144.8M Octopus Ventures, Firstminute Capital, Hummingbird Ventures +1 101 to 250 2015
7 Sava Technology Sava Technology creates under-skin sensors that continuously monitor glucose, lactate, and ketones. Biotech London Series B $36.0M 2026-10-09 $62.8M SOSV, Balderton Capital, Social Starts +1 101 to 250 2016
8 Apoha Apoha is a start-up that has not yet publicly launched. Biotech London Series A $36.0M 2026-06-03 $36.0M Plug and Play, Innovate UK, Intel Ignite +2 1 to 10 2021
9 Alchemab Therapeutics Alchemab Therapeutics develops protective antibodies to prevent hard-to-treat diseases. Biotech London Series A $33.6M 2026-07-09 $151.1M DCVC, RA Capital Management, DHVC +2 51 to 100 2019
10 EpilepsyGTx EpilepsyGTx develops gene therapies to improve management of focal refractory epilepsy in late-stage clinical development. Biotech Canterbury Series A $33.0M 2025-12-10 $43.0M UCL Technology Fund, HTH 1 to 10 2021

Table 2. Biotech startups in the United Kingdom: the 10 largest rounds of the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Most active investors

By companies backed
#InvestorTypeLocation CompaniesShare Funded, 12 monthsLatest
1 Innovate UK Entrepreneurship program Swindon, United Kingdom 30 5% 8 Bioliberty, Apoha, CellCentric
2 SFC Capital Angel group Northwich, United Kingdom 11 2% 1 Corryn Biotechnologies
3 Scottish Enterprise Government investment office Glasgow, United Kingdom 10 2% 2 Bioliberty, Mironid
4 Octopus Ventures Venture capital firm London, United Kingdom 10 2% 2 Automata, Infinitopes
5 Future Planet Capital Venture capital firm London, United Kingdom 9 1% 2 CellCentric, Nuclera
6 Oxford Science Enterprises Venture capital firm Oxford, United Kingdom 8 1%
7 SOSV Venture capital firm Princeton, United States 6 1% 1 Sava Technology
8 Techstars Startup accelerator New York, United States 6 1%
9 Sofinnova Partners Venture capital firm Paris, France 5 1% 2 T-Therapeutics, Mironid
10 Eos Venture capital firm Saint Andrews, United Kingdom 5 1% 1 Bioliberty
11 Parkwalk Advisors Venture capital firm London, United Kingdom 4 1% 1 Brainomix
12 IP Group Venture capital firm London, United Kingdom 4 1% 1 Microbiotica
13 Old College Capital University program Edinburgh, United Kingdom 4 1% 1 Bioliberty
14 IQ Capital Venture capital firm London, United Kingdom 4 1% 1 Imperagen
15 Verve Ventures Venture capital firm Zug, Switzerland 4 1% 1 Nuclera

Table 3. Biotech startups in the United Kingdom: the funds recorded as investors in the most companies. Latest: companies they back that raised in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Sectors

SectorsCompaniesShareTotal raised
Health care 457 72% $9.5B
Software 132 21% $1.2B
Artificial intelligence 86 13% $888.1M
Hardware 27 4% $370.4M
Fintech 16 3% $15.5M
Cybersecurity 10 2% $26.5M
Education 7 1% $284.5M
Energy 5 1% $56.9M
Commerce 1 0% $11.0M

Table 4. Biotech startups in the United Kingdom by sector. Source: FundingWatcher. Data as of 16 November 2026.

Funding stage

Funding stageCompaniesShareMedian last round
Pre-seed 76 12% $539K
Seed 315 49% $2.1M
Series A 125 20% $12.2M
Series B 72 11% $25.1M
Series C 38 6% $35.0M
Series D+ 12 2% $26.5M

Table 5. Biotech startups in the United Kingdom by stage of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.

Cities

CitiesCompaniesShare
London 242 38%
Cambridge 85 13%
Oxford 47 7%
Edinburgh 22 3%
Manchester 20 3%
Bristol 15 2%
Glasgow 12 2%
Stevenage 10 2%
Newcastle Upon Tyne 9 1%
Reading 8 1%
Nottingham 7 1%
Cardiff 6 1%

Table 6. Biotech startups in the United Kingdom by headquarters city. Source: FundingWatcher. Data as of 16 November 2026.

Rounds by month

Rounds by monthCompaniesShareRaised
November 2026 6 7% $253.3M
October 2026 11 12% $439.4M
September 2026 10 11% $157.3M
August 2026 3 3% $48.3M
July 2026 6 7% $130.4M
June 2026 8 9% $321.1M
May 2026 11 12% $339.3M
April 2026 6 7% $78.5M
March 2026 8 9% $232.3M
February 2026 8 9% $56.6M
January 2026 5 6% $62.8M
December 2025 3 3% $36.5M
November 2025 5 6% $145.1M

Table 7. Biotech startups in the United Kingdom: most recent round by month, last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Most recent round by year

Most recent round by yearCompaniesShareRaised
2026 82 13% $2.1B
2025 64 10% $1.3B
2024 92 14% $1.4B
2023 73 11% $663.4M
2022 57 9% $675.3M
2021 55 9% $1.0B

Table 8. Biotech startups in the United Kingdom by year of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.

Founding year

Founding yearCompaniesShare
2023 or later 72 11%
2020 to 2022 161 25%
2015 to 2019 224 35%
2010 to 2014 100 16%
Before 2010 75 12%

Table 9. Biotech startups in the United Kingdom by founding year. Source: FundingWatcher. Data as of 16 November 2026.

Team size

Team sizeCompaniesShare
1 to 10 298 48%
11 to 50 267 43%
51 to 100 38 6%
101 to 250 19 3%
251 to 500 3 0%
1,001 to 5,000 1 0%

Table 10. Biotech startups in the United Kingdom by headcount. Source: FundingWatcher. Data as of 16 November 2026.

Method

Sources, fields and exclusions of both files: Method.

Questions

How many biotech startups in the United Kingdom are on the list?
638, in the file dated 16 November 2026. 90 of them closed their most recent round in the last 12 months.
What does the CSV contain?
One row per company, 18 columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.
How much does the list cost?
$29 one-time for all 638 rows, no account. Every investor and every startup, two files, cost $99. With founder contacts, up to 2 founders or CEOs per company compiled to order and mailed within 24 hours, $349.
What arrives after payment?
At once: the CSV download link, on the page after payment and by mail.
Can I see rows before buying?
The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
How current is the data?
The file is dated 16 November 2026. The download link serves the current file each time it is opened.

Biotech startups in the United Kingdom: 638 rows, CSV, $29 one-time.

At once: the CSV download link, on the page after payment and by mail.

Columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.

With founder contacts: $349 one-time. List CSV right after payment; up to 2 verified founder or CEO emails per company compiled to order within 24 hours.

Not sure about the data?

Download a free 10-row sample first. No account, no payment.

Biotech startups in the United Kingdom by funding stage

Other sectors in United Kingdom

Biotech startups elsewhere

Cite: FundingWatcher, 638 funded biotech companies in the United Kingdom, 16 November 2026. https://fundingwatcher.com/startups/biotech/united-kingdom/